McKesson General Medical
This article was originally published in The Gray Sheet
Columbia/HCA replaces Owens & Minor with McKesson as the medical/surgical supplier to Columbia member health care facilities under a five-year agreement announced May 28. The deal, which is expected to increase McKesson's revenues "by more than $450 mil. annually once fully implemented," is part of a comprehensive health care supply agreement between the firms that is expected to generate $1 bil. annually for McKesson. Owens & Minor says that the "greatest impact" from the contract's cancellation is expected to be felt "in 1999 rather than this year." Under the contract, which was to run through May 1999, Owens & Minor's annual sales volume was approximately $360 mil., or about 11% of the firm's total sales. However, the contract's "contribution as a percent of profits is lower than that percentage," the company maintains
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.